U-Blot® Research Grade Anti-SARS-CoV-2 NTD (CM25)Cat. No. WA2368$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-SARS-CoV-2 NTD (CM25)Cat. No. WA2368
U-Blot® Research Grade Anti-RSV pre-F/pre-Fusion glycoprotein F0 (ADI-14442)Cat. No. WA2367
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (RSV7.10)Cat. No. WA2366
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (RSD5)Cat. No. WA2365
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (RSB1)Cat. No. WA2364
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (R4.C6)Cat. No. WA2363
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (R1.42)Cat. No. WA2362
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (L66)Cat. No. WA2361
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (hRSV90)Cat. No. WA2360
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (hRSV106)Cat. No. WA2359
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (F4)Cat. No. WA2358
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (CR9501)Cat. No. WA2357